Largest, most representative Axial Spondyloarthritis data registry available for licensing, analytics, and collaboration

Research-Grade RWD in AxSpA

Unmet Need

Disease with no cure

With no cure for AxSpA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

Deep Clinical Data


AxSpA patients followed prospectively with deep clinical, lab, and other linked data

*Counts complete through Q4 2023

Analytics & Modeling


AxSpA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Specialized Data

Why OM1 AxSpA?


Sample Use Cases

» Feasibility
» Comparative Effectiveness
» Passive Safety
» Natural History


Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases


Starzyk K, Kumparatana P, Meng R, Probst J. Characterization of Non-radiographic Axial Spondyloarthritis Patients and the Burden of Disease in Routine Clinical Practice. ACR Convergence, November 12-14, 2022.

Award-Winning Research Team

Our team of award-winning researchers have authored hundreds of publications, including scientific posters, articles in peer-reviewed journals, white papers, and books.

Request a Meeting

  • This field is for validation purposes and should be left unchanged.